Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abvc Biopharma Inc (NQ: ABVC )

0.5488 -0.0011 (-0.20%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abvc Biopharma Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
What's Going On With ABVC BioPharma Stock?
ABVC BioPharma, Inc. (NASDAQ: ABVC) shares are rocketing higher Tuesday. 
Via Benzinga
US Stocks Mixed; Pfizer Earnings Beat Views
U.S. stocks were mixed this morning, with the Dow Jones trading slightly higher on Tuesday. Following the market opening Tuesday, the Dow traded up 0.03% to 35,568.68 while the NASDAQ fell 0.57% to... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
ABVC Signs a Term Sheet to Earn Licensing Fees of up to $20M and Royalties of 5-12% of Net Sales
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Intellectual Property
Exposures Intellectual Property
Stocks That Hit 52-Week Lows On Monday
  On Monday, 27 stocks hit new 52-week lows. 
Via Benzinga
Why ABVC Biopharma Stock Is Roaring Higher
ABVC BioPharma, Inc. 
Via Benzinga
ABVC BioPharma Announces Closing on $1.75 Million Registered Direct Offering
FREMONT, CA - (NewMediaWire) - July 31, 2023 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology,... 
Via NewMediaWire
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 59 companies set new 52-week lows. 
Via Benzinga
Why ABVC Biopharma Stock Is Trading Higher
ABVC Biopharma Inc (NASDAQ: ABVC) shares are trading higher by 3.21% to $4.03 Tuesday morning after the company announced a 1-for-10 reverse stock split. 
Via Benzinga
Why ABVC BioPharma Shares Are Rising Today
ABVC BioPharma, Inc. (NASDAQ: ABVC) shares are trading higher on Monday after the company  
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday, 56 stocks hit new 52-week lows. 
Via Benzinga
ABVC BioPharma Announces Pricing of $1.75 Million Registered Direct Offering
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Dow Jumps 100 Points; Fed Raises Interest Rates By 0.25%
U.S. stocks traded mixed toward the end of trading on Wednesday after the Federal Reserve announced interest-rate decision. The Dow traded up 0.29% to 35,541.39 while the NASDAQ fell 0.17% to... 
Via Benzinga
Crude Oil Down 1%; Boeing Posts Upbeat Results
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Wednesday. The Dow traded up 0.14% to 35,489.18 while the NASDAQ fell 0.43% to 14,083.68. The S&P 500,... 
Via Benzinga
ABVC Signs Term Sheet to Acquire Real Estate Assets for Strategic Investments
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Why Universal Health Services Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting China approval of the company's Maxlinear merger. 
Via Benzinga
Why Expion360 Holdings Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
ABVC BioPharma Announces Reverse Stock Split
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. 
Via Benzinga
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's trading, 46 companies set new 52-week lows. 
Via Benzinga
The New CEO of ABVC BioPharma Takes Steps to Help Improve Cash Efficiency
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 43 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
ABVC BioPharma, Inc. Announces New CEO as It Targets Further Growth
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ABVC BioPharma Subsidiary BioKey Projects $1.0 Million Proceeds From Dietary Supplement Production
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ABVC BioPharma ADHD Phase II Part 2 Clinical Study First Subject Enrolled at UCSF
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
ABVC BioPharma Announces Collaboration With MerDury BioPharma for New Product Development and Commercialization
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.